Nuclear stocks, including NuScale (+17%), Oklo, Nano Nuclear, and uranium supplier Centrus (+13%), surged following the U.S. Army's launch of the "Janus Program" to deploy commercially owned and operated micro nuclear reactors. This initiative, driven by President Trump's executive orders to accelerate advanced reactor development by 2028, aims to scale up developers' businesses amid growing market enthusiasm fueled by AI power demand. While investor speculation is high, particularly for companies yet to deploy reactors or generate significant revenue, Goldman Sachs has advised caution on Oklo.
The U.S. Army's launch of the "Janus Program" to deploy commercially owned and operated micro nuclear reactors has significantly boosted nuclear sector equities, with NuScale (SMR) surging 17% and uranium supplier Centrus (LEU) up 13%. This initiative, driven by President Trump's executive orders mandating a military installation reactor by September 2028, aims to accelerate advanced reactor deployment and help developers scale their businesses. The market's strong positive reaction, characterized by a speculative tone, is further fueled by increasing AI power demand and the supportive political environment. The program's focus on commercial operation suggests a potential pathway for these nascent technologies to achieve broader market adoption and scale. However, investor enthusiasm appears largely speculative, as evidenced by companies like Oklo (OKLO) and Nano Nuclear (NNE) rallying despite having no deployed reactors or generated revenue. NuScale, while posting $8 million in Q2 revenue, also lacks deployed reactors. Goldman Sachs' recent caution on Oklo underscores the inherent risks and early-stage nature of these investments.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment
